Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma
Clinical trial NCT06069778 · TERMINATED
Trial details
- NCT number
- NCT06069778
- Sponsor
- BioNTech SE
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2024-09-18
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.